Clinical study on the effects of fecal bacteria transplantation on uric acid and intestinal barrier function in gout patients

Effects of fecal bacteria transplantation on uric acid and intestinal barrier function in patients with gout

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034584

Enrollment

Unknown

Registered

2020-07-11

Start date

2017-06-01

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gout

Interventions

Hyperuricemia patients with gout :fecal microbiota transplantation

Hyperuricemia patients without gout :Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. aged >=18 years; 2. diagnosed with gout according to the Clinical Gout Diagnosis Criteria[12]; 3. treated with uric-acid-lowering drugs for more than one year, but still with hyperuricemia and suffering from acute gout flares twice or more a year.

Exclusion criteria

Exclusion criteria: 1. pregnancy; 2. gastrointestinal infection, cardiopulmonary failure or serious liver diseases; 3. rejection to conduct transendoscopic enteral tubing.

Design outcomes

Primary

Measure	Time frame
uric acid;intestinal barrier;symptoms;	—

Countries

China

Contacts

Public ContactXie Wenrui

The First Affiliated Hospital of Guangdong Pharmaceutical University

wenruix@gmail.com+86 13535049456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026